학술논문

BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma
Document Type
Article
Source
In: Cancer discovery. (Cancer discovery, 1 February 2019, 9(2):210-219)
Subject
Language
English
ISSN
21598290